SOLIGENIX, INC. — Director's Dealing 2009

Jul 9, 2009

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DOR BIOPHARMA INC (DORB)
CIK: 0000812796
Period of Report: 2009-06-04

Reporting Person: Lapointe Gregg Anthony (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2009-06-04	Stock Options (right to buy)	$.14	A	37500	Acquired	2019-06-03	Common Stock (37500)	Direct

Footnotes

F1: Upon election to the Board of Directors, the Company granted Mr. Lapointe options to purchase 37,500 shares of the Company?s common stock the pro-rated amount of stock options for election to the Board of Directors.